UNSPSC 51172114: Amifloverine

This classification denotes an antispasmotic agent with the molecular formula C16H27NO3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier X154DLC3EY, chemically known as 2-(3,5-diethoxyphenoxy)triethylamine but generally known as amifloverine, which bears US NIH Compound Identifier 168913. European Medicines Agency schedules Amifloverine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05429MIG.

UNSPSC 51172114 Amifloverine is a Commodity code under which state and local governments procure drug-testing services for criminal justice and offender-supervision programs. The scope encompasses specimen collection, screening and confirmation testing (immunoassay with LC/MS/MS or GC/MS confirmation), alternative matrices (oral fluid and hair), electronic result reporting, and staffing of collection sites. Testing is performed on a per-test basis with flexible service models allowing vendors to price screening alone, confirmation alone, or bundled screening with automatic confirmation of positives. Vendors must maintain SAMHSA, state, or CAP lab certification. Issuing bodies under this code include county community supervision and corrections departments, which retain discretion to split awards across multiple vendors and often structure contracts with multi-year terms and optional renewal periods.

Collin County Community Supervision and Corrections Department posted RFP 2026-327 on September 25, 2026, seeking offender specimen collection and drug testing services with an estimated contract value of $600,000 and a response deadline of July 23, 2026. The scope includes staffing two collection sites in Plano and McKinney with approximately 25,031 annual tests (5,452 five-panel screens and 18,006 six-panel screens), operation of an Interactive Voice Response system for randomized testing notifications, and pricing subject to annual redetermination capped at 3.0 percent increases. The contract term runs two years from September 1, 2026, with three optional one-year renewals. Evaluation scored vendor understanding (30 points), firm qualifications (25 points), client references (15 points), and cost (30 points), with optional Phase 2 demonstrations worth up to 30 additional points. The anticipated award date is August 10, 2026, with funding from the Texas Department of Criminal Justice-Community Justice Assistance Division.